For decades, cataract surgeons have used handheld instruments to perform some of the most challenging parts of the procedure. Today, the cataract surgeons at Tallman Eye Associates are performing these steps with a new, FDA market cleared laser system called CATALYS™.
CATALYS™ combines a femtosecond laser, 3D imaging, sophisticated software and a number of other innovative features that make the cataract procedure highly customized, gentler and significantly more precise than manual surgery. The laser treatment takes approximately three minutes and causes little or no discomfort to patients.
Developed by Silicon Valley-based OptiMedica Corp., CATALYS™ is a new FDA market cleared medical device that features a state-of-the-art laser, advanced 3D imaging, and many other innovative features that can bring numerous benefits to Houston Eye Associates patients.
Every eye has a unique size and shape. CATALYS™’ advanced 3D imaging technology builds a 3D map of each eye and tailors the treatment to that map. This enables the cataract surgeons at Tallman Eye Associates to create a customized treatment plan that accounts for the unique anatomical features of each eye.
CATALYS™ is a next generation laser cataract surgery platform that combines a femtosecond laser, integrated 3D Optical Coherence Tomography (OCT) imaging, and OptiMedica’s breakthrough pattern scanning technology all into one system. Distinguishing features include a Liquid Optics™ Interface that ensures stable system-patient attachment and optimizes the optical path to the patient’s eye, and a proprietary Integral Guidance™ mapping system that ensures the femtosecond laser pulses are delivered safely and precisely to the intended location.
Tallman Eye Associates strives for excellence in Ophthalmology and Laser Vision Correction. Because we offer procedures that cover so many aspects of eye care we thought you might be interested in hearing the experiences of our patients.